biopharma risk
When Will The Biotech Sky Fall?
If you lived through the dot-com stock market crash of March 11, 2000, you probably have some appreciation for the present day Henny Pennys who fear the sky will soon fall for biotech. One of the key trends fueling the alarm is the continued surge in biopharmaceutical company valuations.  Continue Reading..
negotiation skill and communication
How Good Are Your Negotiation Skills?
I had never heard the phrase “the curse of knowledge” before attending this year’s DCAT Week conference. But on my way home from NYC, of all the new facts, topics, and concepts I had crammed into my brain at the show, it was this one that persistently kept coming to the forefront.  Continue Reading..
Pharma contract manufacturing organization (CMO) awards logo
Presenting The CMO Leadership Awards — A Humbling Experience In Trust
I imagine it's a rare occurrence for someone to pause and ponder if what they are putting into or on their body to be safe. As human beings, we place a high degree of faith in the companies that manufacture the BioPharmaceutical products we use on a daily basis.   Continue Reading..
idea and innovation in biopharma business
Where Do Good Ideas Come From?
We often refer to innovation in the business world as having a link to serendipity. “We just happened to be in the right place at the right time — a lucky break.” But is this really the case?   Continue Reading..
kite pharmaceuticals - cancer immunotherapy
Does A Full Room At BIO CEO Indicate A Company Past Its Tipping Point?
Follow the Twitter hashtag #BIOCEO15 and look for the tweets touting “standing room only” to determine the companies investors consider hot at the 7th Annual BIO CEO & Investor Conference.  Continue Reading..
Life Sciences editor Rob wright
A Behind The Scenes Look At The 2015 J.P. Morgan Healthcare Conference
At the 3rd Annual J.P. Morgan Healthcare Conference (JPM) if you want to gather the vital statistics on how a biopharmaceutical company’s leadership team really feels, from my perspective, the best place to do so is during the much-less-scripted JPM breakout sessions — assuming of course, you can get a seat.  Continue Reading..
drug development companies in biopharma
Can We Really Trust “Greedy” Drug Development Companies To Find Cures?
Some of the industry’s misdeeds discussed at this year’s FDA/CMS Summit include “price gouging” of approved breakthroughs drugs, using approved Risk Evaluation and Mitigation Strategies (REMS) to prevent generic competition, and arguing that distribution of peer-reviewed journal articles and medical textbooks to practicing clinicians should be protected by the first amendment of the constitution.   Continue Reading..
outsourced pharma west connections with the biopharma industry
Why Outsourced Pharma West 2014 Proved Pivotal In Connecting Collaborators
When I think of why I go to a conference, it isn’t usually geared toward filling my rolodex with a collection of business cards with which I struggle to place a name with a face. Instead, I strive to fill my network with connections of potential collaborators who are also interested in moving our industry forward. From my perspective, this was most certainly achieved at Outsourced Pharma West (OPW) 2014.  Continue Reading..
leadership qualities and leadership skills
Do You Have A Future In Leadership?
While preparing for a recent trip to the west coast, I packed a copy of Leaders in Transition by Steve Broe. Author of a leadership lessons article in Life Science Leader magazine’s December 2014 issue, Broe was kind enough to send me a signed copy of his book. Although it is written from the perspective of a leader transitioning from one organization to another, even if leaving your current...  Continue Reading..
checkboxes
What Makes For A Good Industry Session Conference Proposal?
When I asked Jordan Warshafsky, partner at Ashton Tweed, why he decided to serve as a member of the 2015 BIO International Convention educational program planning committee he replied, “Given that this year’s Convention is being held in my hometown, I thought that being a committee member was a way of giving back.  I hope that being a member will, in some small way, begin to repay my gratitude for all those who have helped me...  Continue Reading..
Rob Wright author page

Rob Wright

Rob Wright was chief editor of Life Science Leader magazine from 2011-2021. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, moderated, and served as a speaker at industry and academic conferences, and served as co-chair for the 2015 and 2018 BIO International conference’s educational planning committee. Wright’s 500+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma. He can be followed on Twitter @RfwrightLSL